Børresen-Dale AL - Search Results

1

BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations.

Holstege H, Horlings HM, Velds A, Langerød A, Børresen-Dale AL, van de Vijver MJ, Nederlof PM, Jonkers J. Holstege H, et al. BMC Cancer. 2010 Nov 30;10:654. doi: 10.1186/1471-2407-10-654. BMC Cancer. 2010. PMID: 21118481 Free PMC article.

2

p53 polymorphism and risk of cervical cancer.

Helland A, Langerød A, Johnsen H, Olsen AO, Skovlund E, Børresen-Dale AL. Helland A, et al. Nature. 1998 Dec 10;396(6711):530-1; author reply 532. doi: 10.1038/25034. Nature. 1998. PMID: 9859987 No abstract available.

3

BRCA1 screening in patients with a family history of breast or ovarian cancer.

Arver B, Claro A, Langerød A, Børresen-Dale AL, Lindblom A. Arver B, et al. Genet Test. 1999;3(2):223-6. doi: 10.1089/gte.1999.3.223. Genet Test. 1999. PMID: 10464672

4

High frequency of skewed X inactivation in young breast cancer patients.

Kristiansen M, Langerød A, Knudsen GP, Weber BL, Børresen-Dale AL, Orstavik KH. Kristiansen M, et al. J Med Genet. 2002 Jan;39(1):30-3. doi: 10.1136/jmg.39.1.30. J Med Genet. 2002. PMID: 11826021 Free PMC article.

5

The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas.

Langerød A, Bukholm IR, Bregård A, Lønning PE, Andersen TI, Rognum TO, Meling GI, Lothe RA, Børresen-Dale AL. Langerød A, et al. Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1684-8. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12496062

6

BUB1 infrequently mutated in human breast carcinomas.

Langerød A, Strømberg M, Chin K, Kristensen VN, Børresen-Dale AL. Langerød A, et al. Hum Mutat. 2003 Nov;22(5):420. doi: 10.1002/humu.9194. Hum Mutat. 2003. PMID: 14517964

7

Different gene expression patterns in invasive lobular and ductal carcinomas of the breast.

Zhao H, Langerød A, Ji Y, Nowels KW, Nesland JM, Tibshirani R, Bukholm IK, Kåresen R, Botstein D, Børresen-Dale AL, Jeffrey SS. Zhao H, et al. Mol Biol Cell. 2004 Jun;15(6):2523-36. doi: 10.1091/mbc.e03-11-0786. Epub 2004 Mar 19. Mol Biol Cell. 2004. PMID: 15034139 Free PMC article.

8

Mutation of GATA3 in human breast tumors.

Usary J, Llaca V, Karaca G, Presswala S, Karaca M, He X, Langerød A, Kåresen R, Oh DS, Dressler LG, Lønning PE, Strausberg RL, Chanock S, Børresen-Dale AL, Perou CM. Usary J, et al. Oncogene. 2004 Oct 7;23(46):7669-78. doi: 10.1038/sj.onc.1207966. Oncogene. 2004. PMID: 15361840

9

Gene expression profiling of breast cancer in relation to estrogen receptor status and estrogen-metabolizing enzymes: clinical implications.

Kristensen VN, Sørlie T, Geisler J, Langerød A, Yoshimura N, Kåresen R, Harada N, Lønning PE, Børresen-Dale AL. Kristensen VN, et al. Clin Cancer Res. 2005 Jan 15;11(2 Pt 2):878s-83s. Clin Cancer Res. 2005. PMID: 15701881 Review.

10

TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival.

Kringen P, Wang Y, Dumeaux V, Nesland JM, Kristensen G, Borresen-Dale AL, Dorum A. Kringen P, et al. BMC Cancer. 2005 Oct 17;5:134. doi: 10.1186/1471-2407-5-134. BMC Cancer. 2005. PMID: 16229746 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

508 results

Search Page